Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study.
Saved in:
| Title: | Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study. |
|---|---|
| Authors: | Ruane, Peter1 (AUTHOR) pjruane@ruaneclinicalresearch.com, Strasser, Simone I.2 (AUTHOR), Gane, Edward J.3 (AUTHOR), Hyland, Robert H.4 (AUTHOR), Shao, Jiang4 (AUTHOR), Dvory‐Sobol, Hadas4 (AUTHOR), Tran, Tram4 (AUTHOR), Stamm, Luisa M.4 (AUTHOR), Brainard, Diana M.4 (AUTHOR), Nyberg, Lisa5 (AUTHOR), Shafran, Stephen6 (AUTHOR) |
| Source: | Journal of Viral Hepatitis. Jun2019, Vol. 26 Issue 6, p770-773. 4p. |
| Database: | Academic Search Ultimate |
| ISSN: | 13520504 |
|---|---|
| DOI: | 10.1111/jvh.13067 |
